NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/05/2026
Back to search
Official data from USPTO
ALLERGOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ALLERGOPHARMA
ST13
US500000079144549Class
5, 9, 10, 44
Filing
79144549
Registration
4815182
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
02/06/2026
Trademark type
Word
Nice classes
5, 9, 10, 44
Filing date
01/15/2014
Registration date
09/22/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/05/2026
Last transaction
02/06/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Reinbek, DE
Examiner
LAM, HAI-LY HUYNH
Current location
Historical data usage
Holders and representatives
Holders
Allergopharma GmbH & Co. KG
Allergopharma GmbH & Co. KG
A. K. (pessoa física)
Representatives
Michael J. Leonard FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsin particular for the treatment of allergies; biological and chemical preparations for medical and pharmaceutical purposes for use in the treatment of allergies; vaccines; diagnostic preparations for medical purposesin particular diagnostic preparations for allergies
Class 9
In-vivo and in-vitro diagnostics apparatus and instruments for scientific use in diagnosing allergies
Class 10
Medical apparatus and instruments for diagnosing or treating allergies; diagnostic apparatus for medical purposes for detecting allergies; syringes for medical purposes; hypodermic syringes
Class 44
Medicinal services in the nature of providing a website featuring information in the field of allergy medicine ; conducting of medicinal and clinical studies of allergies for medical diagnostic or treatment purposes; medical assistance
Publications
History of USPTO decisions and trademark events.
55 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
02/05/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/26/2026
ES71
TEAS SECTION 71 RECEIVED
09/22/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/22/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/03/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/24/2023
INPC
INVALIDATION PROCESSED
05/24/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/17/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/17/2022
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
08/17/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/16/2022
ES71
TEAS SECTION 71 RECEIVED
03/18/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/19/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/07/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/22/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/26/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/18/2016
FIMP
FINAL DISPOSITION PROCESSED
03/18/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/22/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2015
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/18/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/02/2015
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/02/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2015
PUBO
PUBLISHED FOR OPPOSITION
07/07/2015
GPNX
NOTIFICATION PROCESSED BY IB
07/03/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/17/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/17/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/29/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
05/08/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/08/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
05/08/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/08/2015
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/13/2015
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/13/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/11/2014
GNFR
FINAL REFUSAL E-MAILED
11/11/2014
CNFR
FINAL REFUSAL WRITTEN
11/11/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2014
ALIE
ASSIGNED TO LIE
10/14/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2014
RFNT
REFUSAL PROCESSED BY IB
05/08/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/23/2014
RFRR
REFUSAL PROCESSED BY MPU
04/23/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/22/2014
CNRT
NON-FINAL ACTION WRITTEN
04/21/2014
DOCK
ASSIGNED TO EXAMINER
04/18/2014
MAFR
APPLICATION FILING RECEIPT MAILED
04/01/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2014
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
03/27/2014
Continuous trademark protection
Get notified about every new filing that threatens ALLERGOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.